BRIEF-Watson gets approval from European commission to buy Actavis

Oct 5 (Reuters) - Watson Pharmaceuticals Inc :

* Receives approval from European commission for pending actavis acquisition

* Says transaction remains subject to regulatory approval in the United States

from the federal trade commission

* Says Watson continues to expect the transaction to close in the fourth

quarter of 2012

((Bangalore Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))